Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Mirum’s Long-Term Alagille Data Support Case For Early Filing

Nov 28 2019

• By Joseph Haas

Liver Meeting Update, Boston 2019 — Mirum is advancing former Shire compounds in cholestatic liver disease

Related Content

Shire's Alagille syndrome drug fails Phase II trial

Apr 09 2015

Newly Hatched Mirum To Focus On Rare Liver Disease Candidates Shelved By Shire

Nov 07 2018

Related Companies

Takeda Pharmaceutical Co. Ltd.

Mirum Pharmaceuticals, Inc.

Takeda Pharmaceutical Co. Ltd.

Lumena Pharmaceuticals

Additional Topics

Business Strategies Clinical Trials Drug Approval Standards Rare Diseases Research & Development Liver & Hepatic BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.